In a fairly remarkable study, progesterone given shortly after traumatic brain injury (TBI) appears to cut the risk of death by 50%. This is important because currently there is no good treatment that improves the outcome of TBI.

Furthermore, those patients given the progesterone had significantly less disability.

A recent study out of the New York University School of Medicine reveals that the drug Exelon (Rivastigmine) can improve memory in patients who have moderate-to-severe memory loss from traumatic brain injury.

Specifically, improvements were seen in measures of